Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis. (Q46236723)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

title

Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

Minoru Hasegawa

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

Manabu Fujimoto

10

1 reference

ORCID Public Data File 2021

author name string

Yutaka Kuwatsuka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

Fumihide Ogawa

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

Yohei Iwata

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

Eiji Muroi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

Toshihide Hara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

Motoi Takenaka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

Kazuhiro Shimizu

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

Shinichi Sato

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 February 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

120-125

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

Immunopathogenesis of systemic sclerosis

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Antinuclear antibody in systemic sclerosis (scleroderma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Histone deacetylase inhibitors: molecular mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Activation of the growth-differentiation factor 11 gene by the histone deacetylase (HDAC) inhibitor trichostatin A and repression by HDAC3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Histone deacetylases (HDACs): characterization of the classical HDAC family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Class II histone deacetylases: from sequence to function, regulation, and clinical implication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

The emerging therapeutic potential of sirtuin-interacting drugs: from cell death to lifespan extension

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

New therapeutic targets in cancer: the epigenetic connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Histone deacetylases, transcriptional control, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Role of Class I and Class II histone deacetylases in carcinoma cells using siRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

A review of depsipeptide and other histone deacetylase inhibitors in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Targeting histone deacetylases for the treatment of cancer and inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

HDAC inhibitors as anti-inflammatory agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Inhibition of IL-8 gene expression in Caco-2 cells by compounds which induce histone hyperacetylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Modulation of renal disease in MRL/lpr mice by suberoylanilide hydroxamic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Antibody response to a non-conserved C-terminal part of human histone deacetylase 3 in colon cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Preliminary criteria for the classification of systemic sclerosis (scleroderma)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

The 1982 revised criteria for the classification of systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Polymyositis and dermatomyositis (second of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Polymyositis and dermatomyositis (first of two parts)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Ongoing immunoglobulin class switch DNA recombination in lupus B cells: analysis of switch regulatory regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

B cell receptor-independent stimuli trigger immunoglobulin (Ig) class switch recombination and production of IgG autoantibodies by anergic self-reactive B cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1/Cip1) expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

The immunobiology of systemic sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Protective autoantibodies: role in homeostasis, clinical importance, and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Presence of anti-La autoantibody is associated with a lower risk of nephritis and seizures in lupus patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

Histone deacetylase inhibitors decrease Toll-like receptor-mediated activation of proinflammatory gene expression by impairing transcription factor recruitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080/08916930802406300

10.1080/08916930802406300

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19021012 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference